Press Releases in 2011

Novus Biologicals announced today a new LAMP1 Antibody (catalog number NBP1-49668) that is useful as a endosome marker and a mast cell marker, as well as in research on membrane trafficking and chaperones. This LAMP-1 antibody was made using SDIX Genomic Antibody Technology^TM (GAT^TM). 

Novus Biologicals announced today a new GOLM 1antibody (catalog number NBP1-50627) which is useful as a golgi apparatus marker and for signal transduction research. This GOLM-1antibody was made using SDIX Genomic Antibody Technology^TM (GAT^TM). 

Novus Biologicals announced today a new FUS antibody (catalog number NBP1-50623) for neuroscience and cancer research.  This FUS antibody was made using SDIX Genomic Antibody Technology^TM (GAT^TM). 

Novus Biologicals is excited to announce the release of a new NAPSIN1 Antibody (NB110-68133) for Napsin research.

Novus Biologicals announced today a new DEPDC6 Antibody (catalog number NBP1-49674) for the study of cancer and mTOR signaling. This DEPDC6 antibody was made using SDIX Genomic Antibody Technology^TM (GAT^TM). 

Novus Biologicals announced today a new USP22 antibody (catalog number NBP1-49644), a Golgi Apparatus marker and useful for the study of ubiquitin-dependent metabolic pathways. This USP22 antibody was made using SDIX Genomic Antibody Technology^TM (GAT^TM). 

Novus Biologicals is excited to introduce a new anti-MAP2K1IP1antibody (catalog number NBP1-50631) to the bioscience industry for the study of cancer and signal transduction.  This MAP2K1-IP1 antibody is of particular importance as it was made using SDIX Genomic Antibody Technology^TM (GAT^TM). 

Novus Biologicals launched a new Nkx6.1 antibody (catalog number NBP1-49672) for the study of pancreatic stem cell markers and signal transduction. This Nkx6.1 antibody was made using SDIX's Genomic Antibody Technology^TM (GAT^TM). 

Novus Biologicals is excited to announce a new PINK1 antibody (catalog number NBP1-49678) for the study of mitochondrial markers and neurodegeneration. This PINK 1 antibody was made using SDIX Genomic Antibody Technology^TM (GAT^TM). 

Novus Biologicals and GeneGo, a Thomson Reuters business, have partnered to bring useful resources to bioscience researchers.  Novus' antibody catalog, which represents 10,000+ proteins, is now overlaid with 800+ molecular pathways in GeneGo's MetaCore^TM and MetaDrug^TM software suites.